NEVVI Medicare utilization intelligence

← back

FINTEL, ANDREWD.O. NPI 1578876843 Clinician

Hematology-Oncology · SALEM, VA

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 16 years since medical school (class of 2010, self-reported to CMS)
Location SALEM, VA · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 64 codes billed · 69,881 disclosed volume (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
ONCOLOGY AND HEMATOLOGY ASSOCIATES OF SOUTHWEST VIRGINIA INC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2016-05

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Volume Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J0185 Injection, aprepitant, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J0897 Injection, denosumab, 1 mg
80053 Blood test, comprehensive group of blood chemicals
J2469 Injection, palonosetron hcl, 25 mcg
36415 Insertion of needle into vein for collection of blood sample
J1626 Injection, granisetron hydrochloride, 100 mcg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96375 Injection of additional new drug or substance into vein
96413 Administration of chemotherapy into vein, 1 hour or less
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
J9045 Injection, carboplatin, 50 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
82784 Gammaglobulin (immune system protein) measurement
84443 Blood test, thyroid stimulating hormone (tsh)
96372 Injection of drug or substance under skin or into muscle
J3489 Injection, zoledronic acid, 1 mg
84480 Thyroid hormone, t3 measurement, total
82378 Carcinoembryonic antigen (cea) protein level
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
84436 Thyroxine (thyroid chemical), total
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
83521 Measurement of immunoglobulin light chains
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J1200 Injection, diphenhydramine hcl, up to 50 mg
82607 Cyanocobalamin (vitamin b-12) level
J3490 Unclassified drugs
96417 Administration of additional new drug or substance into vein, 1 hour or less
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
84153 Psa (prostate specific antigen) measurement, total
96415 Administration of chemotherapy into vein, each additional hour
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
83615 Lactate dehydrogenase (enzyme) level
84550 Uric acid level, blood
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
84439 Thyroxine (thyroid chemical), free
96374 Injection of drug or substance into vein
96361 Infusion into a vein for hydration, each additional hour
J7030 Infusion, normal saline solution , 1000 cc
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96411 Administration of additional new drug or substance into vein using push technique
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99195 Drawing of blood for a medical problem
99442 Telephone medical discussion with physician, 11-20 minutes
96523 Irrigation of implanted venous access drug delivery device
96360 Infusion into a vein for hydration, 31-60 minutes
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
99441 Telephone medical discussion with physician, 5-10 minutes
82746 Folic acid level, serum
99497 Advance care planning, first 30 minutes

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.